Angiotensin II receptor blocker prevents upper gastrointestinal bleeding in hypertensive patients with chronic kidney disease not on dialysis

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 7, 2015-07 ,pp. : 722-728

John Wiley & Sons Inc

Access to resources Recommend Favorite

Blood pressure response to angiotensin II, low-density lipoprotein cholesterol and polymorphisms of the angiotensin II type 1 receptor gene in hypertensive sibling pairs

By Vuagnat Albert   Giacché Mara   Hopkins Paul   Azizi Michel   Hunt Steven   Vedie Benoît   Corvol Pierre   Williams Gordon   Jeunemaitre Xavier  

Journal of Molecular Medicine, Vol. 79, Iss. 4, 2001-05 ,pp. : 175-183

Springer Publishing Company

Access to resources Recommend Favorite

Chronic Beneficial Effects of Type 1 Angiotensin II Receptor Antagonist in Patients with Chronic Hypoxemic Pulmonary Diseases

By  

Cardiology, Vol. 97, Iss. 2, 2002-04 ,pp. : 111-112

Karger

Access to resources Recommend Favorite

Long-term clinical and economic outcomes associated with angiotensin II receptor blocker use in hypertensive patients

By Swindle Jason P.   Buzinec Paul   Iorga ŞŞerban R.   Ramaswamy Krishnan   Panjabi Sumeet  

Current Medical Research and Opinion, Vol. 27, Iss. 9, 2011-09 ,pp. : 1719-1731

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic effects of angiotensin II type 1 receptor blocker, irbesartan, on non-alcoholic steatohepatitis using FLS-ob/ob male mice

By                

International Journal of Molecular Medicine, Vol. 30, Iss. 1, 2012-01 ,pp. : 107-113

Spandidos Publications

Access to resources Recommend Favorite